Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
---|
06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
06/14/2001 | WO2001042201A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect |
06/14/2001 | US20010003747 Useful in treating or in preventing melatoninergic disorders |
06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
06/13/2001 | EP1106608A1 Substituted (dihydro)benzoxazine and (dihydro)benzothiazine derivatives, process for their preparation and pharmaceutical compositions containing them |
06/13/2001 | CN1067071C Carboline derivatives |
06/12/2001 | US6245871 Group 8-10 transition metal olefin polymerization catalysts |
06/12/2001 | US6245804 Contraceptives; urogenital disorders |
06/12/2001 | CA2080917C New pharmacologically active catechol derivatives |
06/07/2001 | WO2001040214A1 Bryostatin analogues, synthetic methods and uses |
06/07/2001 | WO2001040202A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides |
06/07/2001 | WO2001030749B1 Novel compounds |
06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
06/07/2001 | DE19958164A1 Aryl-substituierte heterozyklische Enaminone Aryl-substituted heterocyclic Enaminones |
06/07/2001 | CA2394002A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides |
06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
06/06/2001 | EP1104412A1 Tace inhibitors |
06/06/2001 | EP1104411A1 Calcilytic compounds |
06/06/2001 | EP1104298A2 Heterocyclic thioesters or ketones for vision and memory disorders |
06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
06/06/2001 | CN1297888A 2-(3,5-=-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-radical-4-o-tolyl-pyridine-3-radical)-isobutyryl |
06/06/2001 | CA2328553A1 Novel derivatives (dihydro)benzoxazine and (dihydro)benzothiazine substitutes, process for preparing them and pharmaceutical compositions containing them |
06/05/2001 | US6242645 Biological activity enhancer, deoxofluorination agent of interest in medicinal and agrochemical products |
06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
06/05/2001 | US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
05/31/2001 | WO2001037826A1 Npyy5 antagonists |
05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
05/31/2001 | DE19949237A1 Vorstufenverbindung für Radiodiagnostika Precursor for diagnostic radiopharmaceuticals |
05/31/2001 | DE10058310A1 2-(3,5-Bistrifluormethylphenyl)-N-methyl-N-(6- morpholin-4-yl-4-o-tolylpyridin -3-yl ) isobutyramid 2- (3,5-Bis-trifluoromethyl) -N-methyl-N- (6-morpholin-4-yl-4-o-tolylpyridine -3-yl) -isobutyramide |
05/30/2001 | EP1103545A1 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
05/30/2001 | EP1102756A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
05/30/2001 | EP1102742A2 Compounds and compositions for delivering active agents |
05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
05/30/2001 | EP0815106B1 3-aryluracils and intermediates for their preparation |
05/30/2001 | CN1066443C 1,3-oxazin-4-one derivs, and herbicide contg. same |
05/29/2001 | US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis |
05/29/2001 | US6239148 Treatment of painful, hyperalgesic and/or inflammatory conditions in which c-fibers play a role by eliciting neurogenic pain, insulin resistance in diabetes mellitus or aging, inhibit insulin antagonizing peptide, |
05/25/2001 | WO2001036403A1 Urea derivatives as anti-inflammatory agents |
05/25/2001 | WO2001018005A8 Process for the preparation of benzoxazine derivatives and intermediates therefor |
05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
05/23/2001 | CN1066136C Intermediate of pyrido-benzoxazine derivative and preparation method |
05/22/2001 | US6235927 Process for the separation of a mixture of enantiomers |
05/22/2001 | US6235901 Can be polymerized and/or copolymerized by catonic polymerization; can be crosslinked and are useful in coatings, inks, overprint varnishes, and surface treatment applications. |
05/22/2001 | US6235778 Anticoagulants |
05/22/2001 | US6235735 Aftertreatment of radiation therapy |
05/17/2001 | WO2001034583A1 Antifungal sordaricin derivatives |
05/17/2001 | WO2001034582A2 Sordaricin derivatives having antifungal activity |
05/17/2001 | WO2001034581A1 High char yield benzoxazine compositions |
05/16/2001 | EP0839136B1 BENZO[g]QUINOLINE DERIVATIVES |
05/16/2001 | CN1295479A Beta 2-adrenergic receptor agonist |
05/15/2001 | CA2238978C Retroviral protease inhibiting compounds |
05/09/2001 | CN1294592A Process for preparing (-) pyridobenzoxazine carboxylic acid derivatives |
05/09/2001 | CN1294513A Pharmaceutically active morpholinol |
05/08/2001 | US6228862 Increasing adipocyte differentiation |
05/03/2001 | WO2001030749A1 Novel compounds |
05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
05/02/2001 | EP1095016A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
05/02/2001 | EP1094826A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors |
05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
05/02/2001 | CN1293665A New compounds and their use as positive AMPA receptor modulators |
05/02/2001 | CN1065237C Cyclopentane-and-cyclo pentene-beta-amino acids |
05/01/2001 | US6225312 Piperazine and piperidine compounds |
04/26/2001 | WO2001028992A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
04/26/2001 | CA2386910A1 New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
04/25/2001 | EP0885263B1 Benzophenoxazine dyes |
04/25/2001 | CN1292791A Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
04/24/2001 | US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase. |
04/19/2001 | WO2001027122A1 Pre-cursor for radiodiagnostic agents and the production thereof |
04/19/2001 | WO2001026641A2 Morpholinol derivatives for the treatment of obesity |
04/18/2001 | EP1091945A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists |
04/18/2001 | EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
04/17/2001 | US6218544 Heterocyclic esters and amides |
04/17/2001 | US6218429 Tricyclic compounds, their production and use |
04/17/2001 | US6218390 Morpholinone and morpholine derivatives and uses thereof |
04/17/2001 | US6218359 Treating autoimmune, arthritic, tumor diseases |
04/11/2001 | EP1091211A1 Metal chelate containing compositions for use in chemiluminescent assays |
04/11/2001 | EP1090914A2 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |
04/10/2001 | CA2032593C 2-(1-substituted-2-imidazolin-2-yl)benzoic and nicotinic acids and a method for their preparation |
04/05/2001 | WO2001023435A1 Polymerization compositions and methods |
04/03/2001 | US6211240 O-benzyl oxime ether derivatives and their use as pesticides |
04/03/2001 | CA2102772C Azetidinone compound and process for preparation thereof |
03/29/2001 | WO2001021577A2 Melanin concentrating hormone antagonist |
03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
03/29/2001 | CA2386474A1 Melanin concentrating hormone antagonist |
03/28/2001 | EP1086087A1 Crystalline efavirenz |
03/28/2001 | EP1086076A1 Sulfonamide inhibitors of aspartyl protease |
03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |